52 Week Range
As of on the New York Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Anthem Intends To Reaffirm Net Income Guidance For FY 2019 To Be More Than $18.34 Per Share, Including About $0.96 Per Share Of Net Unfavorable Items
Anthem Inc Prices Three-Part Notes Offering Of Up To $2.5 Bln
Anthem Says Challenges Being Faced By Medicaid Business Remain Isolated To A "Handful Of States"
Anthem, Inc. is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products. It also provides an array of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs and other administrative services. It provides an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits and radiology benefit management.
Insurance (Accident & Health)
220 Virginia Avenue
Elizabeth E. Tallett
Independent Chairman of the Board
Gail Koziara Boudreaux
President, Chief Executive Officer, Director
Felicia F. Norwood
EVP and President, Government Business Division
John E. Gallina
Chief Financial Officer, Executive Vice President
Prakash R. Patel
Executive Vice President and President, Diversified Business Group
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
Anthem Inc <ANTM.N> shares fell as much as 4% on Wednesday after the U.S. health insurer missed Wall Street expectations for a key medical cost gauge as a result of higher costs of selling Medicaid health plans for low-income customers.
Anthem Inc reported an 8% rise in second-quarter profit on Wednesday as the U.S. health insurer benefited from higher sales of its government-backed health plans.
Anthem Inc on Wednesday posted a better-than-expected quarterly profit and laid out its plans to transition most customers to its revamped pharmacy benefits business this year.
Health insurer Anthem Inc reported an 18.2 percent rise in quarterly profit on Wednesday, as revenue from its commercial and government businesses rose.
The U.S. House Committee on Energy and Commerce on Wednesday launched an investigation into 12 health insurers, including Anthem Inc and UnitedHealth Group, over their sale of short-term plans.
Anthem Inc <ANTM.N> surprised Wall Street on Wednesday by moving up the launch of its in-house pharmacy benefits management business, sending shares 10 percent higher as investors welcomed the decision after rival health insurers signed multibillion-dollar deals joining...
Anthem Inc reported a 3 percent rise in quarterly revenue on Wednesday as the health insurer benefited from premium rate increases.
Anthem Inc <ANTM.N> on Wednesday said its own expectations for 2019 earnings are ahead of current Wall Street estimates and the health insurer also raised its 2018 profit forecast, and its shares rose as much as 5 percent.
Anthem Inc reported quarterly profit that topped analysts' estimates on Wednesday on lower medical costs and the No.2 U.S. health insurer raised its full-year adjusted earnings forecast.
Japan's Takeda Pharmaceutical Co Ltd <4502.T> on Wednesday boosted its annual operating profit outlook by a third after second-quarter earnings surged on strong global sales of its drugs for bowel disease and multiple myeloma.
Anthem Inc reported a 28.5 percent rise in quarterly profit on Wednesday, as the U.S. health insurer reined in medical costs.
Takeda Pharmaceutical Co Ltd on Wednesday raised its annual operating profit outlook to 268.9 billion yen.
Takeda Pharmaceutical Co Ltd <4502.T> has proposed to European regulators it could sell a Shire <SHP.L> treatment in development due to concerns of overlap in inflammatory bowel disease treatments and its own drug Entyvio as it seeks clearance for the two companies' merger.
Takeda Pharmaceutical Co Ltd <4502.T> said on Thursday Japan's Fair Trade Commission had approved its $62 billion (£47.3 billion) acquisition of Shire Plc <SHP.L>, bringing the Japanese firm closer to sealing a deal that will make it a global top 10 drugmaker.
Takeda Pharmaceutical Co Ltd said on Thursday Japan's Fair Trade Commission had approved its $62 billion acquisition of Shire Plc, bringing the Japanese firm closer to sealing a deal that will make it a global top 10 drugmaker.
Anthem Inc <ANTM.N> said on Monday it has partnered with Walmart Inc <WMT.N> to launch a program in January 2019 that will allow its Medicare Advantage plan customers to purchase over-the-counter medications from the retailer's stores and website.
Anthem Inc <ANTM.N> reported a better-than-expected profit on Wednesday, driven by higher premiums and lower patient medical costs even as fewer people enrolled in its insurance plans.
Anthem Inc reported a 23 percent rise in quarterly profit on Wednesday, helped by premium rate increases.
* ANTHEM INC - FINANCIAL TERMS OF TRANSACTION WERE NOT DISCLOSED
A federal judge on Tuesday dismissed a lawsuit brought against Express Scripts Holding Co <ESRX.O> by shareholders who accused the pharmacy benefits manager of inflating its share price by hiding its deteriorating relationship with its largest customer, Anthem Inc <ANTM.N>.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.